tert-Butyl 6-cyano-2-(2-(4-ethyl-3-iodophenyl)propan-2-yl)-1H-indole-3-carboxylate, 98%, 5g

3-Methylfuran (stabilised with Hydroquinone), 98.0%, 1g

4-Bromobenzyl Bromide>98.0%(GC)500g

tert-Butyldichloro(phenyl)silane>95.0%(GC)1g

(2,6-Dichloropyrimidin-4-yl)-(4-fluorophenyl)methanone, 95.0%, 250mg

(2R)-4,4-Difluoropyrrolidine-2-carboxylic acid, 97%, 5g

6-Bromobenzo[d]oxazole, 95.0%, 10g

Sample vials with short thread ND9 Vial kit, HPLC-certified, Clear glass, with labelling space, 1 Set

5-(4-Methylpiperazin-1-yl)-2-nitroaniline, 95.0%, 5g

6-Chloro-4-hydroxy-2-methyl-2H-thieno[2,3-e]-1,2-thiazine-3-carboxylic acid methyl ester 1,1-dioxide, 97%, 1g

1-Butylcyclohexanol, 97.0%, 25g

METHYL 3-BROMO-1H-INDAZOLE-4-CARBOXYLATE, 95%, 5g

[3-(1-methyl-1H-benzimidazol-2-yl)propyl]amine dihydrochloride hydrate, 95.0%, 1g